Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: Dual drug-loaded nano-platform for targeted cancer therapy: toward clinical therapeutic efficacy of multifunctionality

Fig. 3

a Hemolysis assays of NLCs (a: saline, b: deionized water, c: NLC, d: RGE-NLC, e: R9dGR-NLC). b X-ray of different formations (a: GA + PTX, b: Blank-NLC, c: the physical mixture of NLC’s formulation and GA + PTX, d: GA/PTX-NLC, e: RGE-GA/PTX-NLC, f: R9dGR-GA/PTX-NLC). c The quantitative results of hemolysis assay of NLCs in vitro (mean ± SD, n = 3). d The variations of transmittance of NLCs in 50% FBS over 48 h (mean ± SD, n = 3). e, f GA and PTX release profiles from different formulations in vitro (mean ± SD, n = 3)

Back to article page